CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Ucb Biopharma against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Aug 7, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Il-17 A/F Heterologous Polypeptides And Therapeutics Uses ThereofGENENTECHApr 23, 2020
Immunoglobulin PreparationCSL BEHRINGSep 11, 2019
Antibodies And Vaccines For Use In Therapeutic And Diagnostic Methods For Alpha-Synuclein-Related DisordersBIOARCTICAug 21, 2019
Methods Of Altering Bone Growth By Administration Of Sost Or Wise Antagonist Or AgonistOSSIFI MABDec 21, 2018
Method For Inactivating Proteases By Ph Change In A Liquid Obtained From A Cell CultureBOEHRINGER INGELHEIMNov 28, 2018
Prevention Of Disulfide Bond Reduction During Recombinant Production Of PolypeptidesGENENTECHAug 29, 2018
Rapid Method For Cloning And Expression Of Cognate Antibody Variable Region Gene SegmentsFHOFFMANN LA ROCHEAug 15, 2018

Explore Ucb Biopharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 7, 2025
Patent NumberGrant DateTitleTotal Oppositions
Mar 27, 2024Cell Culture Methods4
Aug 30, 2023Cell Culture Methods2
May 10, 2023Novel Tnf Structure For Use In Therapy1
Jun 6, 2018Polyvinylpyrrolidone For The Stabilization Of A Solid Dispersion Of The Non-Crystalline Form Of Rotigotine2
Jun 14, 2017Multi-Day Patch For The Transdermal Administration Of Rotigotine2

Top competitors of Ucb Biopharma

List of top competitors of Ucb Biopharma based on patent oppositions.